A pragmatic contouring guideline for salivary gland structures in head and neck radiation oncology: The MOIST target

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 1, 2013, Pages 70-76

  Hoebers, Frank ^a   Yu, Eugene ^a,b   Eisbruch, Avi ^c   Thorstad, Wade ^d   O'sullivan, Brian ^a   Dawson, Laura A ^a   Hope, Andrew ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MICHIGAN   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

intensity modulated radiation treatment; minor salivary glands; normal tissue delineation; salivary anatomy; xerostomia

Indexed keywords

ARTICLE; CHEEK MUCOSA; COMPUTER ASSISTED TOMOGRAPHY; HARD PALATE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LAMINA PROPRIA; LIP; MASTICATORY MUSCLE; PALATE; PAROTID GLAND; PLATYSMA MUSCLE; RADIATION INJURY; SALIVARY GLAND; SOFT PALATE; STERNOCLEIDOMASTOID MUSCLE; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND; XEROSTOMIA;

HEAD AND NECK NEOPLASMS; HUMANS; OBSERVER VARIATION; RADIATION ONCOLOGY; SALIVARY GLANDS; SIALOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84872948848     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31823a538e     Document Type: Article

References (46)

1. Ringash J, Warde P, Lockwood G, et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys. 2005;61:1403-1407 (Pubitemid 40470421)
2. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695-704 (Pubitemid 32515326)
3. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: Pathophysiology, clinical course and supportive treatment. Support Care Cancer. 1997;5:281-288 (Pubitemid 27305078)
4. Braaksma MM, Wijers OB, van Sornsen de Koste JR, et al. Optimisation of conformal radiation therapy by intensity modulation: Cancer of the larynx and salivary gland function. Radiother Oncol. 2003;66:291-302 (Pubitemid 36556048)
5. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577-587 (Pubitemid 29462636)
6. Blanco AI, Chao KS, El Naqa I, et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:1055-1069 (Pubitemid 40884418)
7. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873-4879 (Pubitemid 350220416)
8. Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg. 2003;27: 832-837 (Pubitemid 37022398)
9. Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol. 2001;61:275-280 (Pubitemid 33127232)
10. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys. 2001; 49:907-916 (Pubitemid 32184597)
11. Braam PM, Terhaard CH, Roesink JM, et al. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2006; 66:975-980 (Pubitemid 44633513)
12. Astreinidou E, Dehnad H, Terhaard CH, et al. Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys. 2004;58:124-131 (Pubitemid 38010345)
13. Meirovitz A, Murdoch-Kinch CA, Schipper M, et al. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;66:445-453 (Pubitemid 44332730)
14. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004; 58:663-673 (Pubitemid 38221119)
15. Fox PC, Sarras AK, Bowers MR, et al. Oral and sialochemical findings in patients with autoimmune rheumatic disease. Clin Exp Rheumatol. 1987;5:123-126 (Pubitemid 17114989)
16. Franzen L, Funegard U, Ericson T, et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck: A consecutive study of salivary flow and patient discomfort. Eur J Cancer. 1992;28:457-462
17. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006;66:981-991 (Pubitemid 44633504)
18. Roesink JM, Schipper M, Busschers W, et al. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: Implications for future trials. Int J Radiat Oncol Biol Phys. 2005;63:1006-1009 (Pubitemid 41505276)
19. Saarilahti K, Kouri M, Collan J, et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol. 2006; 78:270-275
20. Jellema AP, Doornaert P, Slotman BJ, et al. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy? Radiother Oncol. 2005;77:164-171 (Pubitemid 41682382)
21. Murdoch-Kinch CA, Kim HM, Vineberg KA, et al. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:373-382
22. Astreinidou E, Roesink JM, Raaijmakers CP, et al. 3D MR sialography as a tool to investigate radiation-induced xerostomia: Feasibility study. Int J Radiat Oncol Biol Phys. 2007;68: 1310-1319 (Pubitemid 47176799)
23. Konings AW, Faber H, Cotteleer F, et al. Secondary radiation damage as the main cause for unexpected volume effects: A histopathologic study of the parotid gland. Int J Radiat Oncol Biol Phys. 2006;64:98-105 (Pubitemid 41831215)
24. Williams PL. Gray's Anatomy, the Anatomical Basis of Medicine and Surgery. 38th ed Churchill Livingstone; 1995
25. Hermans R. Head and Neck Cancer Imaging. Springer; 2006
26. Chisholm DM, Mason DK. Salivary gland disease. Br Med Bull. 1975;31:156-158
27. Roesink JM, Terhaard CH, Moerland MA, et al. CT-based parotid gland location: Implications for preservation of parotid function. Radiother Oncol. 2000;55:131-133 (Pubitemid 30229987)
28. Kim HC, Han MH, Moon MH, et al. CT and MR imaging of the buccal space: Normal anatomy and abnormalities. Korean J Radiol. 2005;6:22-30 (Pubitemid 40470502)
29. Guyton AC. Textbook of Medical Physiology. 7th ed W.B. Saunders Company; 1986
30. Silvers AR, Som PM. Salivary glands. Radiol Clin North Am. 1998;36:941-966. vi. (Pubitemid 28421899)
31. Tabak LA. In defense of the oral cavity: Structure, biosynthesis, and function of salivary mucins. Annu Rev Physiol. 1995;57: 547-564
32. Milne RW, Dawes C. The relative contributions of different salivary glands to the blood group activity of whole saliva in humans. Vox Sang. 1973;25:298-307
33. Tabak LA, Levine MJ, Mandel ID, et al. Role of salivary mucins in the protection of the oral cavity. J Oral Pathol Med. 1982;11: 1-17 (Pubitemid 12182153)
34. Lee YYP, Wong KT, King AD, et al. Imaging of salivary gland tumours. Eur J Radiol Head Neck Cancer. 2008;66:419-436
35. Tabor EK, Curtin HD. MR of the salivary glands. Radiol Clin North Am. 1989;27:379-392 (Pubitemid 19071809)
36. Teresi LM, Lufkin RB, Wortham DG, et al. Parotid masses: MR imaging. Radiology. 1987;163:405-409 (Pubitemid 17068916)
37. Ric Harnsberger H. Diagnostic Imaging: Head and Neck. Elsevier; 2005
38. Geets X, Daisne JF, Tomsej M, et al. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between pre- and per-treatment studies. Radiother Oncol. 2006; 78:291-297
39. Rasch C, Keus R, Pameijer FA, et al. The potential impact of CTMRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1997;39:841-848 (Pubitemid 27486072)
40. Breen SL, Publicover J, De Silva S, et al. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys. 2007;68:763-770 (Pubitemid 46818731)
41. O'Daniel JC, Rosenthal DI, Garden AS, et al. The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy. Am J Clin Oncol. 2007;30:191-198 (Pubitemid 46573256)
42. Collier DC, Burnett SS, Amin M, et al. Assessment of consistency in contouring of normal-tissue anatomic structures. J Appl Clin Med Phys. 2003;4:17-24
43. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21:109-122
44. Marks L. A Clinician's View of QUANTEC. AAPM. 2008;35: 2863-2864
45. van de Water TA, Bijl HP, Westerlaan HE, et al. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol. 2009;93:545-552
46. Jones AV, Craig GT, Speight PM, et al. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008;44:407-417 (Pubitemid 351380985)